DuPont has completed its acquisition of Donatelle Plastics, a leading medical device contract manufacturer specializing in components and devices.

According to an SEC filing, the deal was worth $313 million.

“I’m pleased to welcome the talented Donatelle colleagues to DuPont,” said DuPont president Jon Kemp. “We’re excited to add Donatelle’s best-in-class advanced injection molding manufacturing capabilities, and decades-long customer relationships with large medical device equipment manufacturers to E&I’s healthcare offerings.”

With a workforce of more than 400 employees, Donatelle becomes part of the Industrial Solutions line of business within the Electronics & Industrial segment. The acquisition brings complementary advanced technologies and capabilities including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool building.

Donatelle has a strong financial growth potential with offerings aligned to therapeutic areas including electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities.